Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1387508 NEW YORK, NY

Position in PCRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,146,611
+$8,021 QoQ
Shares Held
50,735
+15.3% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. PCRX ranks #7 (5.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 PCRX
Pacira BioSciences, Inc.
This page
50,735 $1,146,611

All Filings in PCRX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,146,611 50,735
2025-12-31 $1,138,590 43,995
2025-09-30 $941,506 36,535
2025-06-30 $579,216 24,235
2025-03-31 $604,824 24,339
2024-12-31 $368,039 19,535
2024-09-30 $330,121 21,935
2024-06-30 $555,520 19,417
2024-03-31 $424,420 14,525
2023-12-31 $225,518 6,684
2023-06-30 $280,089 6,990
2022-06-30 $573,497 9,837
2022-03-31 $560,646 7,346
2021-12-31 $711,630 11,827
2020-06-30 $810,504 15,447
2020-03-31 $415,403 12,389